NEP and APN, the major enkephalinases, have been reported to regulate opioid signaling in the gut, which is considered the cause of impaired intestinal motility, intestinal barrier dysfunction, and colonic inflammation in IBD patients (Sałaga et al., 2017). The gene discussed is MME; the disease is inflammatory bowel disease.